menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

The Importance of Extended Genotyping in Cervical Cancer Screening: The Special Case of HPV 31

Program Information
Recommended

Program Information

ReachMD Healthcare Image
RestartResume

Could an HPV test with extended genotyping that can individually identify HPV 16, 18, 31, and other genotypes change the way we screen for and manage patients with cervical cancer?

  • Overview

    Now that vaccinated women have entered the screening population, we are seeing HPV 16 and 18 decreasing. These changes in HPV genotype prevalence may have a significant impact on the clinical management of cervical cancer, and an HPV test with extended genotyping may change the way we screen for cervical cancer as well. Joining Dr. Matt Birnholz to discuss the role of HPV extended genotyping in cervical cancer screening and the importance of identifying HPV 31 is Dr. Mark Stoler, Professor of Pathology and Clinical Gynecology at the University of Virginia Health System.

Schedule20 Oct 2021
Webpack App